Page 39 - பல்கலைக்கழகம் மருத்துவமனை சவுத்தாம்ப்டன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time First UK COVID-19 vaccine study for pregnant women launches in Southampton The first COVID-19 vaccine study in the UK recruiting pregnant women has been launched across several National Institute for Health Research (NIHR) sites, including University Hospital Southampton. The phase 2/3 study aims to further understand the safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in healthy pregnant women, with approximately 235 volunteers involved throughout the UK. Following updated guidance from the Joint Committee on Vaccination and Immunisation (JCVI) released in April, pregnant women are now offered approved COVID-19 vaccines at the same time as the rest of the UK population, based on their age and clinical risk group. Real-world data from the United States has been collected, in which over 100,000 pregnant women have been vaccinated (mainly with mRNA vaccines including Pfizer-BioNTech), without any safety concerns raised.

United statesUnited kingdomAndrew ustianowskiChrissie jonesNational institute for health researchCommittee on vaccinationUniversity hospital southamptonNational clinical lead for the united kingdomVaccine research programmeNational instituteHealth researchUniversity hospitalJoint committeeMaternal immunisationAssociate professorPaediatric infectious diseases